Oral Health Group
News

Crosstex Announces Retirement of Andrew Whitehead


July 10, 2017
by Crosstex

Cantel Medical Corporation subsidiary, Crosstex International, Inc., today announced the retirement of Andrew Whitehead, effective August 1, 2017. Whitehead’s decision to retire will bring to an end a phenomenal 20-year career of continuous service with the Company.

Whitehead will transition to a part-time consultant role where he will continue to focus on the Company’s efforts to execute its aggressive acquisition strategy.

“Andy is a strong and experienced leader who has set a vision that will position us well in the future. His contributions, determination and work ethic have been highly instrumental to our success. Andy is a true professional and I look forward to continuing to work with him in his consultant role,” said Gary Steinberg, President of Crosstex International.

Whitehead has over 40 years’ experience and is a leader in the dental market. He joined Crosstex in 1996, and during his tenure, the Company saw substantial growth and his contributions to the Company have been highly instrumental to its success. He played an integral role advancing the Company’s acquisition strategy, most recently with DentaPure and Accutron transactions.

Whitehead was recently elected Chairman of the Organization for Safety, Asepsis and Prevention Foundation Board following his service as a member of the Board of Directors.  He is also a Board member of the Dental Trade Alliance Foundation (DTAF).  His dedicated involvement in both organizations has helped raise in excess of $2M to support and provide the ongoing awareness of infection prevention, education and the providing of dental care to the underserved community.  His involvement with these and other industry non-profit organizations has been and will continue to be an integral part of his future, both professionally and personally.


About Crosstex
Crosstex International, Inc., a Cantel Medical company, manufactures a wide array of unique and innovative infection prevention and compliance products for the global healthcare industry. Founded in 1953 and headquartered in Hauppauge, New York, Crosstex is a recognized leader for its portfolio of waterline treatment, biological monitoring, sterility assurance packaging and personal protection equipment (PPE). Sold in more than 100 countries, the range of products distributed to medical, dental and veterinary practices and facilities include our award winning (5 consecutive years) SECURE FIT® technology face masks, DENTAPURE® waterline treatment cartridges and LIQUID ULTRA™ waterline treatment, SURE-CHECK® sterilization pouches with internal/external multi-parameter indicators, Tyvek pouches with 510K approval, SteamPlus Type 5 chemical integrators, CONFIRM® and PASSPORT® Plus in-office and mail-in biological indicators, and RAPICIDE® OPA/28 high level disinfectant. For more information about the full line of Crosstex infection prevention, patient safety and compliance products, please contact Crosstex at 631-582-6777 or visit www.crosstex.com.

About Cantel Medical
Cantel Medical is a leading global company dedicated to delivering innovative infection prevention products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives. Our products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, hollow fiber membrane filtration and separation products. Additionally, we provide technical service for our products. For further information, visit the Cantel website at www.cantelmedical.com.